tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
PremiumMarket NewsLilly vs. Novo Nordisk: Who Will Lead India’s Growing Obesity-Drug Market?
2M ago
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
Premium
Company Announcements
Cipla Ltd Receives ESG Rating of 66 for FY 2024-25
2M ago
Cipla Ltd Completes Acquisition of Inzpera Healthsciences
Premium
Company Announcements
Cipla Ltd Completes Acquisition of Inzpera Healthsciences
2M ago
Cipla Opens Special Window for Physical Share Transfers
PremiumCompany AnnouncementsCipla Opens Special Window for Physical Share Transfers
7M ago
Cipla Ltd Announces Strong Q1 2025 Financial Results
Premium
Company Announcements
Cipla Ltd Announces Strong Q1 2025 Financial Results
7M ago
Eli Lilly and Cipla’s Diabetes Study: A Potential Game-Changer for Type 2 Diabetes Management
Premium
Company Announcements
Eli Lilly and Cipla’s Diabetes Study: A Potential Game-Changer for Type 2 Diabetes Management
7M ago
Cipla’s Medispray Facility Receives VAI Classification from USFDA
PremiumCompany AnnouncementsCipla’s Medispray Facility Receives VAI Classification from USFDA
10M ago
Cipla Secures USFDA Approval for Nilotinib Capsules, Expanding Oncology Portfolio
Premium
Company Announcements
Cipla Secures USFDA Approval for Nilotinib Capsules, Expanding Oncology Portfolio
12M ago
Cipla’s Sitec Labs Undergoes USFDA Inspection, Receives Two Observations
Premium
Company Announcements
Cipla’s Sitec Labs Undergoes USFDA Inspection, Receives Two Observations
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100